The Impact of Novel Anti-Diabetic Medications on CV Outcomes: A New Therapeutic Horizon for Diabetic and Non-Diabetic Cardiac Patients

Israel Mazin*, Fernando Chernomordik, Paul Fefer, Shlomi Matetzky, Roy Beigel

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'The Impact of Novel Anti-Diabetic Medications on CV Outcomes: A New Therapeutic Horizon for Diabetic and Non-Diabetic Cardiac Patients'. Together they form a unique fingerprint.

Medicine & Life Sciences